The role of mechanistic target of rapamycin (mTOR) complexes signaling in the immune responses

GA Soliman - Nutrients, 2013 - mdpi.com
The mechanistic Target of Rapamycin (mTOR) is an evolutionarily conserved
serine/threonine kinase which is a member of the PI3K related kinase (PIKK) family. mTOR …

Aberrant transcription factors in the cancers of the pancreas

MH Uddin, MN Al-Hallak, PA Philip, H Chen… - Seminars in cancer …, 2022 - Elsevier
Transcription factors (TFs) are essential for proper activation of gene during the process of
organogenesis, differentiation, lineage specificity. Reactivation or dysregulation of TFs …

New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations

HA Mahdy, H Elkady, MS Taghour… - Future Medicinal …, 2023 - Taylor & Francis
Background: VEGFR-2 is one of the most effective targets in cancer treatment. Aim: The
design and semi-synthesis of new theobromine derivatives as potential VEGFR-2 inhibitors …

Semi-synthesized anticancer theobromine derivatives targeting VEGFR-2: in silico and in vitro evaluations

MA Dahab, HA Mahdy, H Elkady… - Journal of …, 2024 - Taylor & Francis
Vascular endothelial cell proliferation and angiogenesis are all crucially impacted by
Endothelial Growth Factor Receptor-2 (VEGFR-2). Its expression is significantly boosted …

Exploring the anticancer properties of a new nicotinamide analogue: Investigations into in silico analysis, antiproliferative effects, selectivity, VEGFR-2 inhibition …

IH Eissa, RG Yousef, M Sami, EB Elkaeed… - … -Research and Practice, 2023 - Elsevier
Background This study focuses on the development and evaluation of (E)-N-(3-(1-(2-(4-
bromobenzoyl) hydrazono) ethyl) phenyl) nicotinamide (BHEPN) as a potential inhibitor of …

New insights into the role of chronic inflammation and cytokines in the etiopathogenesis of gastroenteropancreatic neuroendocrine tumors

M Cigrovski Berkovic, T Cacev, T Catela Ivkovic… - …, 2014 - karger.com
Although previously considered rare, recent epidemiological studies have revealed that the
incidence (3.6/100,000) and prevalence (35/100,000) of gastroenteropancreatic …

Localization of sunitinib, its metabolites and its target receptors in tumour‐bearing mice: a MALDI‐MS imaging study

S Torok, A Vegvari, M Rezeli… - British journal of …, 2015 - Wiley Online Library
Background and Purpose The clinical effects of anti‐angiogenic agents remain
controversial. Therefore, elucidating the pharmacological properties of these compounds is …

Unlocking the synthetic approaches and clinical application of approved small-molecule drugs for gastrointestinal cancer treatment: A comprehensive exploration

XJ Li, P Nie, P Herdewijn, JG Sun - European Journal of Medicinal …, 2023 - Elsevier
Gastrointestinal (GI) cancers encompass a group of malignancies affecting the digestive
system, including the stomach, esophagus, liver, colon, rectum and pancreas. These …

Everolimus in the treatment of patients with advanced pancreatic neuroendocrine tumors: latest findings and interpretations

E Liu, P Marincola, K Öberg - Therapeutic advances in …, 2013 - journals.sagepub.com
Pancreatic neuroendocrine tumors (pNETs) are a heterogeneous group of neoplasms with
various clinical presentations. More than half of patients present with so-called …

RTK/ERK pathway under natural selection associated with prostate cancer

Y Chen, X Xin, J Li, J Xu, X Yu, T Li, Z Mo, Y Hu - PLoS One, 2013 - journals.plos.org
Prostate cancer (PCa) is a global disease causing large numbers of deaths every year.
Recent studies have indicated the RTK/ERK pathway might be a key pathway in the …